Lisata Therapeutics Inc (LSTA)

[whirlybird]

When will there be another secondary offering?

At its current rate of spending, NBS will feel a need for more money within a year. Yes, another secondary offering is inevitable, but when? From the FY 13 report, “Overall, there were ~50% more active clients compared to 2012. Year-end cash balance was $46.1 million. Operating expenses were $38.5 million compared to $32.8 million in 2012.” Another secondary offering will occur a short time after the announcement of positive results from the Preserve study. It will be oversubscribed and the offering price will not be as low proportionately to market price as the last secondary offering.